{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:21:46Z","timestamp":1765369306011,"version":"3.37.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["11\/Y\/B2093"],"award-info":[{"award-number":["11\/Y\/B2093"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012912","name":"Imperial College Healthcare Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.kint.2018.05.028","type":"journal-article","created":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T11:14:05Z","timestamp":1535282045000},"page":"926-936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis"],"prefix":"10.1016","volume":"94","author":[{"given":"Dearbhaile","family":"Dooley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjan M.","family":"van Timmeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent P.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth","family":"Brady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E\u00f3in C.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Fazekas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fionnuala B.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Leacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles D.","family":"Pusey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick W.K.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mehrling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Heeringa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.kint.2018.05.028_bib1","doi-asserted-by":"crossref","first-page":"i59","DOI":"10.1136\/ard.2010.138024","article-title":"Pathogenesis of ANCA-associated vasculitides","volume":"70","author":"Kallenberg","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2018.05.028_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease","volume":"10","author":"Jennette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.kint.2018.05.028_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000368569","article-title":"Limitations of standard immunosuppressive treatment in ANCA-associated vasculitis and lupus nephritis","volume":"128","author":"Tesar","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.kint.2018.05.028_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2009.02.042","article-title":"Enhancing the apoptotic and therapeutic effects of HDAC inhibitors","volume":"280","author":"Frew","year":"2009","journal-title":"Cancer Lett"},{"issue":"suppl 2","key":"10.1016\/j.kint.2018.05.028_bib5","doi-asserted-by":"crossref","first-page":"i46","DOI":"10.1136\/annrheumdis-2011-200593","article-title":"HDAC inhibitor therapy in autoimmunity and transplantation","volume":"71","author":"Hancock","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2018.05.028_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/1871520615666150518092027","article-title":"The alkylating-HDAC inhibition fusion principle: taking chemotherapy to the next level with the first in class molecule EDO-S101","volume":"16","author":"Mehrling","year":"2016","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.kint.2018.05.028_bib7","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1182\/blood.V124.21.2100.2100","article-title":"The alkylating histone deacetylase inhibitor fusion molecule Edo-S101 displays full bi-functional properties in preclinical models of hematological malignancies","volume":"124","author":"L\u00f3pez-Iglesias","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.05.028_bib8","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1182\/blood.V124.21.2249.2249","article-title":"Edo-S101, a new alkylating histone-deacetylase inhibitor (HDACi) fusion molecule, has superior activity against myeloma and B cell lymphoma and strong synergy with proteasome inhibitors in\u00a0vitro","volume":"124","author":"Kraus","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.05.028_bib9","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1038\/s41598-017-07366-7","article-title":"Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression","volume":"7","author":"Di Benedetto","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2018.05.028_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/srep00220","article-title":"Histone deacetylase inhibitors globally enhance H3\/H4 tail acetylation without affecting H3 lysine 56 acetylation","volume":"2","author":"Drogaris","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2018.05.028_bib11","first-page":"254","article-title":"Age-determined severity of anti-myeloperoxidase autoantibody-mediated glomerulonephritis in mice","volume":"32","author":"Wang","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.05.028_bib12","first-page":"60","article-title":"Acute inflammatory response to endotoxin in mice and humans","volume":"12","author":"Copeland","year":"2005","journal-title":"Clin Diag Lab Immunol"},{"key":"10.1016\/j.kint.2018.05.028_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9440(10)62951-3","article-title":"The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies","volume":"167","author":"Xiao","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2018.05.028_bib14","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1172\/JCI40034","article-title":"Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis","volume":"120","author":"Ciavatta","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2018.05.028_bib15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1681\/ASN.2013101092","article-title":"Dysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesis","volume":"26","author":"McInnis","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.05.028_bib16","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1182\/blood.V128.22.4466.4466","article-title":"The first in class, alkylator-histone-deacetylase-inhibitor fusion molecule Edo-S101 in combination with proteasome inhibitors induces highly synergistic pro-apoptotic signaling through UPR activation and suppression of c-Myc and BCL2 in multiple myeloma","volume":"128","author":"Besse","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.05.028_bib17","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood.V126.23.2481.2481","article-title":"The first-in-class alkylating histone-deacetylase inhibitor (HDACi) fusion molecule Edo-S101 exerts potent preclinical activity against tumor cells of Hodgkin lymphoma (HL) including bendamustine-resistant clones","volume":"126","author":"De Filippi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.05.028_bib18","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1182\/blood.V126.23.5354.5354","article-title":"The hybrid molecule, Edo-S101, impairs double strand breaks repair in multiple myeloma and synergizes with bortezomib and dexamethasone","volume":"126","author":"L\u00f3pez-Iglesias","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.05.028_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2005060616","article-title":"Therapeutic effect of anti\u2013TNF-\u03b1 antibodies in an experimental model of anti-neutrophil cytoplasm antibody\u2013associated systemic vasculitis","volume":"17","author":"Little","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.05.028_bib20","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2353\/ajpath.2009.080458","article-title":"Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis","volume":"174","author":"Little","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2018.05.028_bib21","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1681\/ASN.2015050511","article-title":"Urinary soluble CD163 in active renal vasculitis","volume":"27","author":"O\u2019Reilly","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.05.028_bib22","doi-asserted-by":"crossref","first-page":"R315","DOI":"10.1016\/S0960-9822(00)00439-5","article-title":"Checkpoints: how to activate p53","volume":"10","author":"Caspari","year":"2000","journal-title":"Curr Biol"},{"key":"10.1016\/j.kint.2018.05.028_bib23","first-page":"9","article-title":"H2AX phosphorylation: its role in DNA damage response and cancer therapy","volume":"2010","author":"Podhorecka","year":"2010","journal-title":"J\u00a0Nucleic Acids"},{"key":"10.1016\/j.kint.2018.05.028_bib24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2018.05.028_bib25","doi-asserted-by":"crossref","first-page":"38074","DOI":"10.1038\/srep38074","article-title":"Changes in urinary metabolomic profile during relapsing renal vasculitis","volume":"6","author":"Al-Ani","year":"2016","journal-title":"Sci Rep"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818304198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818304198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T03:53:26Z","timestamp":1717214006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818304198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0085253818304198"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.05.028","relation":{},"ISSN":["0085-2538"],"issn-type":[{"type":"print","value":"0085-2538"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}